Session 3: Physical Property Based Crystallization Process Development – Pharma Crystallization Summit

Category : Session 3: Physical Property Based Crystallization Process Development

The Importance of Understanding and Characterising the Physical & Chemical Properties of APIs in the Digital Design of Drug Products

Prof. Kevin Roberts, University of Leeds

Continuous Crystallization and Purification: The Role of Impurity Incorporation Mechanism in Non-Equilibrium Processes

Prof. Allan Myerson, MIT

Co-Crystals Platform to Improve Physical Properties of Early Intermediates during API Manufacturing Process

Dr. Samir Kulkarni, Pfizer

Correlation of Solubility with the Metastable Limit

Prof. Ken Morris, Long Island University